JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹18 Cr | ₹8.49 Cr | ₹4.49 Cr | ₹1.88 Cr |
What is the latest Total Non-Current Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹8.49 Cr |
| Mar2022 | ₹4.49 Cr |
| Mar2021 | ₹1.88 Cr |
How is Total Non-Current Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 43.46 | |
| Mar2024 | ₹18 Cr | 113.41 | |
| Mar2023 | ₹8.49 Cr | 88.81 | |
| Mar2022 | ₹4.49 Cr | 139.42 | |
| Mar2021 | ₹1.88 Cr | - | |
Compare Total Non-Current Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,164.1 Cr | -4.4% | -12.7% | -17% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -4.4% |
-12.7% |
-17% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses